Home › Drug Codes › J Codes › J0695 · ZERBAXA
Updated July 1st, 2026

ZERBAXA J Code: J0695

Injection, ceftolozane 50 mg and tazobactam 25 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J0695, effective October 1, 2026: $10.015 per HCPCS billing unit, down 0.2% from $10.038. From CMS's final file.

?
Medicare Payment Limit ?
$10.038
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
$10.038
/ HCPCS billing unit · APC 9452
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, ceftolozane 50 mg and tazobactam 25 mg
HCPCS Added Date January 1, 2016
Manufacturer Merck Sharp & Dohme Corp
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection, Powder, Lyophilized, For Solution

About ZERBAXA

Zerbaxa is a medication aligned to the HCPCS J Code: J0695 for billing, pricing, and reimbursement purposes in the United States. Classified under Antibiotic, it is administered via the intravenous route and manufactured by Merck Sharp & Dohme Corp.

According to CMS Drug Use Information: Ceftolozane/tazobactam is used to treat a variety of bacterial infections. It is a cephalosporin antibiotic. It works by stopping the growth of bacteria.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
67919-0030-01 Zerbaxa Merck Sharp & Dohme LLC 200 Zerbaxa Intravenous In jection 1 GM/10M… Login for More
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

ZERBAXA Pricing & Reimbursement

J0695 Private Payer Reimbursement
$8.74 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

ZERBAXA CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Zerbaxa (J0695) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

ZERBAXA Medically Unlikely Edits (MUE)

The most billing units of J0695 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 75mg (50mg cft/25mg taz).

Practitioner Office & Hospital Outpatient
60 units / day
= 4,500 mg (50mg cft/25mg taz) per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg (50mg cft/25mg taz) Enter a dose to see how many billing units it is and whether it is under the limit.

ZERBAXA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Complicated intra-abdominal infections Complicated urinary tract infections, including pyelonephritis Hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia
Drug Class
Cephalosporin Antibacterial [EPC]Cephalosporins [CS]beta Lactamase Inhibitor [EPC]beta Lactamase Inhibitors [MoA]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there an available Zerbaxa billing and coding guide?
Billing and coding information for ZERBAXA can be found through Merck. Visit Here →
Are there any available Zerbaxa patient assistance programs?
ZERBAXA patient assistance information can be found through Merck. Visit Here →
Where can I find Zerbaxa prescribing information?
ZERBAXA prescribing information can be found at the link below: Visit Here →
Where can I find Zerbaxa side effect information?
Information regarding ZERBAXA's side effects can be found at MedlinePlus Visit Here →
Does billing ZERBAXA require JZ/JW wastage modifiers?
CMS has identified ZERBAXA(J0695) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to ZERBAXA.

J1335ERTAPENEMInjection, ertapenem sodium, 500 mgMultiple ManufacturersAdded January 1, 2004J0122XERAVAInjection, eravacycline, 1 mgTetraphase PharmaceuticalsAdded October 1, 2019J0458EMBLAVEOInjection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg)AbbvieAdded October 1, 2025J0692CEFEPIMEInjection, cefepime hydrochloride, 500 mgMultiple ManufacturersAdded January 1, 2002J0701Cefepime HCLInjection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mgBaxter HealthcareAdded January 1, 2023J0703Cefepime HCL in DextroseInjection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mgB. Braun Medical IncAdded January 1, 2023J0744CIPRO IVInjection, ciprofloxacin for intravenous infusion, 200 mgHospiraAdded January 1, 2002J2184MEROPENEMInjection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mgB. Braun Medical IncAdded January 1, 2023J2185MEROPENEMInjection, meropenem, 100 mgMultiple ManufacturersAdded January 1, 2004J2280AVELOX I.V.Injection, moxifloxacin, 100 mgMylan PharmaceuticalsAdded January 1, 2004